Ceftriaxone- resistant Neisseria gonorrhoeae, Japan

Emerging Infectious Diseases

Volumn 17, Issue 1, 2011, Pages 148-149

  Ohnishi, Makoto ^a   Saika, Takeshi ^b   Hoshina, Shinji ^c   Iwasaku, Kazuhiro ^d   Nakayama, Shu Ichi ^a   Watanabe, Haruo ^a   Kitawaki, Jo ^d  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b LSI MEDIENCE CORPORATION   (Japan)

^c Hoshina Clinic   (Japan)

^d KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFIXIME; CEFTRIAXONE; LEVOFLOXACIN; PENICILLIN G; SPECTINOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CASE REPORT; FEMALE; GONORRHEA; HUMAN; JAPAN; LETTER; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; NONHUMAN; SEXUALLY TRANSMITTED DISEASE;

ADULT; ANTI-BACTERIAL AGENTS; CEFTRIAXONE; DRUG RESISTANCE, BACTERIAL; FEMALE; GONORRHEA; HUMANS; JAPAN; MICROBIAL SENSITIVITY TESTS; NEISSERIA GONORRHOEAE; PHARYNX; PROSTITUTION;

EID: 78650967538     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1701.100397     Document Type: Letter

References (9)

1. Tapsall JW, Ndowa F, Lewis DA, Unemo M. Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae. Expert Rev Anti Infect Ther. 2009;7:821-834. DOI: 10.1586/eri.09.63
2. Workowski KA, Berman SM, Douglas JM Jr. Emerging antimicrobial resistance in Neisseria gonorrhoeae: urgent need to strengthen prevention strategies. Ann Intern Med. 2008;148:606-613.
3. Tapsall J. Antibiotic resistance in Neisseria gonorrhoeae is diminishing available treatment options for gonorrhea: some possible remedies. Expert Rev Anti Infect Ther. 2006;4:619-628. DOI: 10.1586/14787210.4.4.619
4. Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 19th informational supplement. CLSI document M100-S19. Wayne (PA): The Institute; 2009.
5. Jolley KA. Multi-locus sequence typing. In: Pollard AJ Maiden MCJ, editors. Meningococcal disease: methods and protocols. Totowa (NJ): Humana Press; 2001. p. 173-186.
6. Ohnishi M, Watanabe Y, Ono E, Takahashi C, Oya H, Kuroki T, et al. Spreading of a chromosomal cefi xime resistant penA gene among different Neisseria gonorrhoeae lineages. Antimicrob Agents Chemother. 2010;54:1060-1067. DOI: 10.1128/AAC.01010-09
7. Martin IM, Ison CA, Aanensen DM, Fenton KA, Spratt BG. Rapid sequence-based identifi cation of gonococcal transmission clusters in a large metropolitan area. J Infect Dis. 2004;189:1497-1505. DOI: 10.1086/383047
8. Ito M, Yasuda M, Yokoi S, Ito S, Takahashi Y, Ishihara S, et al. Remarkable increase in central Japan in 2001-2002 of Neisseria gonorrhoeae isolates with decreased susceptibility to penicillin, tetracycline, oral cepharosporins, and fl uoroquinolones. Antimicrob Agents Chemother. 2004;48:3185-3187. DOI: 10.1128/AAC. 48.8.3185-3187.2004
9. Tanaka M, Nakayama H, Huruya K, Konomi I, Irie S, Kanayama A, et al. Analysis of mutations within multiple genes associated with resistance in a clinical isolate of Neisseria gonorrhoeae with reduced ceftriaxone susceptibility that shows a multidrug-resistant phenotype. Int J Antimicrob Agents. 2006;27:20-26. DOI: 10.1016/j.ijantimicag.2005.08.021